Find a Tender
complete
Official procurement procedure
Generic and Biosimilar Cancer Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published33
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"): "Generic and Biosimilar Cancer Medicines". Published status: complete. Published value: Value not published. 33 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
4.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 151 active published awards; 151 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published21 Apr 2023, 08:53 BST | Last source update21 Apr 2023, 08:53 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-0368ee | ||
What is being bought
This Framework Agreement is for the supply of generic and biosimilar cancer medicines to NHS Scotland.
The Goods were separated into forty-one (41) categories, each of which is identified as a “Lot”.
Full details of each awarded Lot is contained in section II.2 of this Notice.
What changed
From the official release history
- tender value changed
21 Apr 2023, 08:53 BST - Status changed to complete
21 Apr 2023, 08:53 BST - Official notice release published
21 Apr 2023, 08:53 BST - Submission deadline changed to published date
21 Apr 2023, 08:53 BST - Published value updated to £59,145,973
16 Sept 2022, 08:41 BST - Status changed to active
16 Sept 2022, 08:41 BST - Official notice release published
16 Sept 2022, 08:41 BST - Submission deadline changed to 17 Oct 2022, 12:00 BST
16 Sept 2022, 08:41 BST - Buyer information updated
16 Sept 2022, 08:41 BST
Lots and requirements (33)
Published by the contracting authority
- Lot 1 · #1Lot 1 Bendamustine Powder For Solution For InfusioncancelledPublished valueNot publishedSupply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #10Lot 10 Doxorubicin Hydrochloride InjectionscancelledPublished valueNot publishedSupply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #12Lot 12 Fluorouracil 50MG/ML InjectioncancelledPublished valueNot publishedSupply of Fluorouracil 50MG/ML Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #13Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #14Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #17Lot 17 Ifosfamide Injection Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #18Lot 18 Irinotecan Hydrochloride InjectioncancelledPublished valueNot publishedSupply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #19Lot 19 Lanreotide Injection Prefilled SyringescancelledPublished valueNot publishedSupply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #2Lot 2 Capecitabine TabletscancelledPublished valueNot publishedSupply of Capecitabine Tablets to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #20Lot 20 Methotrexate Without Preservatives InjectioncancelledPublished valueNot publishedSupply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #21Lot 21 Methotrexate Oral SolutioncancelledPublished valueNot publishedSupply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #23Lot 23 Oxaliplatin Vial SolutioncancelledPublished valueNot publishedSupply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #24Lot 24 Paclitaxel Concentrate For Intravenous InfusioncancelledPublished valueNot publishedSupply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #25Lot 25 Temozolomide CapsulescancelledPublished valueNot publishedSupply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #26Lot 26 Vincristine Without Preservatives InjectioncancelledPublished valueNot publishedSupply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 16 · #27Lot 27 Vinorelbine InjectioncancelledPublished valueNot publishedSupply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 17 · #28Lot 28 Aprepitant CapsulescancelledPublished valueNot publishedSupply of Aprepitant Capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 18 · #3Lot 3 Carboplatin InjectioncancelledPublished valueNot publishedSupply of Carboplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 19 · #31Lot 31 Octreotide InjectioncancelledPublished valueNot publishedSupply of Octreotide Injection. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 20 · #32Lot 32 Filgrastim Pre-Filled SyringecancelledPublished valueNot publishedSupply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 21 · #33Lot 33 Pemetrexed Powder For Solution For Infusion VialscancelledPublished valueNot publishedSupply of Pemetrexed Powder For Solution For Infusion Vials in various presentations to NHS Scotland. The Authority has awarded this Lot as a single-supplier framework.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 22 · #34Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion VialscancelledPublished valueNot publishedSupply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 23 · #37Lot 37 Etoposide InjectioncancelledPublished valueNot publishedSupply of Etoposide Injection to NHS Scotland. The Authority has awarded this Lot as a ranked multi-supplier framework awardContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 24 · #38Lot 38 Dasatinib TabletscancelledPublished valueNot publishedSupply of Dasatinib Tablets to NHS Scotland. The Authority has awarded each product line as a multi-supplier ranked framework agreement to 2 framework participants.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 25 · #39Lot 39 Unranked Multi-Supplier Generic & Biosimilar MedicinescancelledPublished valueNot publishedSupply of a number of Generic & Biosimilar Medicines including bevacizumab solution for infusion, doxorubicin liposomal solution for infusion, rituximab solution for infusion, trastuzumab powder for solution for infusion, sorafenib tablets and thalidomide capsules to NHS Scotland. Each product line has been treated as an individual Lot and awarded as a unranked multi-supplier awardContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 26 · #4Lot 4 Cisplatin InjectioncancelledPublished valueNot publishedSupply of Cisplatin Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 27 · #40Lot 40 Idarubicin Hydrochloride Solution for InfusioncancelledPublished valueNot publishedSupply of Idarubicin Hydrochloride Solution for Infusion. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 28 · #41Lot 41 Single Supplier Generic MedicinescancelledPublished valueNot publishedSupply of a range of generic cancer medicines to NHS Scotland. Each product line has been treated as an individual Lot and awarded to a single Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 29 · #5Lot 5 Cyclophosphamide Injection, Powder For ReconstitutioncancelledPublished valueNot publishedSupply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 30 · #6Lot 6 Cytarabine InjectionscancelledPublished valueNot publishedSupply of Cytarabine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 31 · #7Lot 7 Dacarbazine InjectionscancelledPublished valueNot publishedSupply of Dacarbazine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 32 · #8Lot 8 Disodium Folinate InjectioncancelledPublished valueNot publishedSupply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 33 · #9Lot 9 Docetaxel Concentrate For Solution For InfusioncancelledPublished valueNot publishedSupply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
21 Apr 2023, 08:53 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 23 Dec 2022, 00:00 GMT · £94,841 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £64,942 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £254,428 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £101,239 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £17,172 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £226,125 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £2,785,640 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £360,972 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £55,538 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £193,024 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £346,754 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £748,926 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £117,608 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £132,132 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £54,400 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £116,863 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £135,446 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £1,670,068 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £161,249 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £232,447 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £528,727 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £8,560,798 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £594,456 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £110,072 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £163,444 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £2,531,158 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £11,073,623 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £205,855 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £255,695 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £101,689 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £593,020 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £442,064 - Contract active
Signed 23 Dec 2022, 00:00 GMT · £319,866
Commercial outcome and competition
Awards Accord-UK Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active Accord-UK Ltd Not published · Not published · active Consilient Health Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Mercury Pharma Group Not published · Not published · active medac Pharma LLP Not published · Not published · active Rosemont Pharmaceuticals Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Fresenius Kabi Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active medac Pharma LLP Not published · Not published · active Zentiva Pharma UK Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Ranbaxy (UK) Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active Teva UK Limited, Zentiva Pharma UK Ltd Not published · Not published · active Accord-UK Ltd, Baxter Healthcare Ltd, Celltrion Healthcare United Kingdom Limited, Organon Pharmaceutical UK Ltd, Pfizer Ltd, Roche Products Ltd, Sandoz Ltd, Teva UK Limited, Thornton & Ross, Zentiva Pharma UK Ltd Not published · Not published · active Consilient Health Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Accord-UK Ltd, Consilient Health Ltd, Fresenius Kabi Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Accord-UK Ltd, Aspen Pharmacare UK Limited, Baxter Healthcare Ltd, Bayer Plc, Chugai Pharma UK Ltd, Dr Reddy's Laboratories (UK) Ltd, Flexipharm Austrading Limited, Fresenius Kabi Ltd, Glenmark Pharmaceuticals Europe Ltd, Intrapharm Laboratories Ltd, Kent Pharmaceuticals Ltd, Martindale Pharma, Mercury Pharma Group, Morningside Pharmaceuticals Limited, Neon Healthcare Not published · Not published · active Accord-UK Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Accord-UK Ltd Not published · Not published · active medac Pharma LLP Not published · Not published · active medac Pharma LLP Not published · Not published · active Consilient Health Ltd Not published · Not published · active |
Contracts Lot 1 Bendamustine Powder For Solution For Infusion £94,841 · signed 23 Dec 2022, 00:00 GMT · active Lot 10 Doxorubicin Hydrochloride Injections £64,942 · signed 23 Dec 2022, 00:00 GMT · active Lot 12 Fluorouracil 50MG/ML Injection £254,428 · signed 23 Dec 2022, 00:00 GMT · active Lot 13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials £101,239 · signed 23 Dec 2022, 00:00 GMT · active Lot 14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials £17,172 · signed 23 Dec 2022, 00:00 GMT · active Lot 18 Irinotecan Hydrochloride Injection £226,125 · signed 23 Dec 2022, 00:00 GMT · active Lot 19 Lanreotide Injection Prefilled Syringes £2,785,640 · signed 23 Dec 2022, 00:00 GMT · active Lot 20 Methotrexate Without Preservatives Injection £360,972 · signed 23 Dec 2022, 00:00 GMT · active Lot 21 Methotrexate Oral Solution £55,538 · signed 23 Dec 2022, 00:00 GMT · active Lot 23 Oxaliplatin Vial Solution £193,024 · signed 23 Dec 2022, 00:00 GMT · active Lot 24 Paclitaxel Concentrate For Intravenous Infusion £346,754 · signed 23 Dec 2022, 00:00 GMT · active Lot 2 Capecitabine Tablets £748,926 · signed 23 Dec 2022, 00:00 GMT · active Lot 25 Temozolomide Capsules £117,608 · signed 23 Dec 2022, 00:00 GMT · active Lot 26 Vincristine Without Preservatives Injection £132,132 · signed 23 Dec 2022, 00:00 GMT · active Lot 27 Vinorelbine Injection £54,400 · signed 23 Dec 2022, 00:00 GMT · active Lot 28 Aprepitant Capsules £116,863 · signed 23 Dec 2022, 00:00 GMT · active Lot 31 Octreotide Injection £135,446 · signed 23 Dec 2022, 00:00 GMT · active Lot 32 Filgrastim Pre-Filled Syringe £1,670,068 · signed 23 Dec 2022, 00:00 GMT · active Lot 33 Pemetrexed Powder For Solution For Infusion Vials £161,249 · signed 23 Dec 2022, 00:00 GMT · active Lot 34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials £232,447 · signed 23 Dec 2022, 00:00 GMT · active Lot 38 Dasatinib Tablets £528,727 · signed 23 Dec 2022, 00:00 GMT · active Lot 39 Unranked Multi-Supplier Generic & Biosimilar Medicines £8,560,798 · signed 23 Dec 2022, 00:00 GMT · active Lot 3 Carboplatin Injection £594,456 · signed 23 Dec 2022, 00:00 GMT · active Lot 40 Idarubicin Hydrochloride Solution for Infusion £110,072 · signed 23 Dec 2022, 00:00 GMT · active Lot 37 Etoposide Injection £163,444 · signed 23 Dec 2022, 00:00 GMT · active Lot 17 Ifosfamide Injection Powder For Reconstitution £2,531,158 · signed 23 Dec 2022, 00:00 GMT · active Lot 41 Single Supplier Generic Medicines £11,073,623 · signed 23 Dec 2022, 00:00 GMT · active Lot 4 Cisplatin Injection £205,855 · signed 23 Dec 2022, 00:00 GMT · active Lot 5 Cyclophosphamide Injection, Powder For Reconstitution £255,695 · signed 23 Dec 2022, 00:00 GMT · active Lot 6 Cytarabine Injections £101,689 · signed 23 Dec 2022, 00:00 GMT · active Lot 7 Dacarbazine Injections £593,020 · signed 23 Dec 2022, 00:00 GMT · active Lot 8 Disodium Folinate Injection £442,064 · signed 23 Dec 2022, 00:00 GMT · active Lot 9 Docetaxel Concentrate For Solution For Infusion £319,866 · signed 23 Dec 2022, 00:00 GMT · active |
Bid statistics bids: 4 (lot 1) electronicBids: 4 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 4 (lot 1) smeBids: 0 (lot 1) bids: 3 (lot 10) electronicBids: 3 (lot 10) foreignBidsFromEU: 0 (lot 10) foreignBidsFromNonEU: 3 (lot 10) smeBids: 0 (lot 10) bids: 2 (lot 12) electronicBids: 2 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 2 (lot 12) smeBids: 0 (lot 12) bids: 3 (lot 13) electronicBids: 3 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 3 (lot 13) smeBids: 0 (lot 13) bids: 1 (lot 14) electronicBids: 1 (lot 14) foreignBidsFromEU: 0 (lot 14) foreignBidsFromNonEU: 1 (lot 14) smeBids: 0 (lot 14) bids: 4 (lot 17) electronicBids: 4 (lot 17) foreignBidsFromEU: 0 (lot 17) foreignBidsFromNonEU: 4 (lot 17) smeBids: 0 (lot 17) bids: 5 (lot 18) electronicBids: 5 (lot 18) foreignBidsFromEU: 0 (lot 18) foreignBidsFromNonEU: 5 (lot 18) smeBids: 0 (lot 18) bids: 1 (lot 19) electronicBids: 1 (lot 19) foreignBidsFromEU: 0 (lot 19) foreignBidsFromNonEU: 1 (lot 19) smeBids: 0 (lot 19) bids: 3 (lot 2) electronicBids: 3 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 3 (lot 2) smeBids: 0 (lot 2) bids: 2 (lot 20) electronicBids: 2 (lot 20) foreignBidsFromEU: 0 (lot 20) foreignBidsFromNonEU: 2 (lot 20) smeBids: 0 (lot 20) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contracting authority GB-FTS-4546Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published